Mackay Shields LLC Siga Technologies Inc Transaction History

Mackay Shields LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 31, 2020	SELL	$4.55 - $6.19 $203,416 - $276,736	-44,707 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$3.99 - $5.46 $839,496 - $1.15 Million	-210,400 Reduced 82.48%	44,707 $213,000
Q4 2019 Feb 11, 2020	SELL	$4.34 - $5.86 $545,538 - $736,602	-125,700 Reduced 33.01%	255,107 $1.22 Million
Q3 2019 Nov 01, 2019	SELL	$4.93 - $5.8 $182,903 - $215,180	-37,100 Reduced 8.88%	380,807 $1.95 Million
Q2 2019 Aug 13, 2019	BUY	$5.22 - $6.1 $1.63 Million - $1.91 Million	312,607 Added 296.87%	417,907 $2.37 Million

Q1 2019 May 13, 2019	BUY	$5.66 - $7.89 $595,998 - $830,817	105,300 New	105,300 $633,000

213

35M

74.6K

22.8K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $438M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.